Toxicogenomics: Techniques, Applications, and Challenges

OMICS: Applications in Biomedical, Agricultural, and Environmental Sciences

Volumn , Issue , 2013, Pages 137-182

  Padikasan, Indra Arulselvi ^a   Daniel, Nancy ^a  

^a PERIYAR UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85026927361     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b14289-11     Document Type: Chapter

References (45)

1. Jonic, S., T. Jankovic, V. Gajic, and D. Popovic. 1999. Three machine learning techniques for automatic determination of rules to control locomotion. IEEE Transactions on Biomedical Engineering 46:300-310.
2. Tennant, R.W. 2002. The National Center for Toxicogenomics: Using new technologies to inform mechanistic toxicology. Environmental Health Perspectives 110:A8-A10.
3. Kreuzer, K.A., U. Lass, A. Bohn, O. Landt, and C.A. Schmidt. 1999. LightCycler technology for the quantitation of bcr/abl fusion transcripts. Cancer Research 59:3171-3174.
4. Brown, P.O., and D. Botstein. 1999. Exploring the new world of the genome with DNA microarrays. Nature Genetics 21:33-37.
5. Saeed, A.I., V. Sharov, J. White, J. Li, W. Liang, N. Bhagabati et al. 2003. TM4: A free, open-source system for microarray data management and analysis. Biotechniques 374-378.
6. Gunderson, K.L., F.J. Steemers, G. Lee, L.G. Mendoza, and M.S. Chee. 2005. A genome-wide scalable SNP genotyping assay using microarray technology. Nature Genetics 37(5):549-554.
7. Davis, J.W., F.M. Goodsaid, C.M. Bral, L.A. Obert, and G. Mandakas. 2004. Quantitative gene expression analysis in a nonhuman primate model of antibiotic-induced nephrotoxicity. Toxicology and Applied Pharmacology 200:16-26.
8. Friedman, R.C., K.K. Farh, C.B. Burge, and D.P. Bartel. 2009. Most mammalian mRNAs are conserved targets of microRNAs. Genome Research 19:92-105.
9. Sotiropoulou, G., G. Pampalakis, E. Lianidou, and Z. Mourelatos. 2009. Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell. RNA 15:1443-1461.
10. Aebersold, R., and M. Mann. 2003. Mass spectrometry-based proteomics. Nature 422(6928): 198-207.
11. Liebler, D.C., B.T. Hansen, J.A. Jones, H. Badghisi, and D.E. Mason. 2003. Mapping protein modifications with liquid chromatography-mass spectrometry and the SALSA algorithm. Advances in Protein Chemistry 65:195-216.
12. Righetti, P.G., and A. Bossi. 1997. Isoelectric focusing in immobilized pH gradients: Recent analytical and preparative developments. Analytical Biochemistry 247(1):1-10.
13. Von Eggeling, F., A. Gawriljuk, W. Fiedler, G. Ernst, U. Claussen, J. Klose et al. 2001. Fluorescent dual colour 2D-protein gel electrophoresis for rapid detection of differences in protein pattern with standard image analysis software. International Journal of Molecular Medicine 8(4):373-377.
14. Gygi, S.P., G. Corthals, L. Zhang, Y. Rochon, and R. Aebersold. 2000. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proceedings of the National Academy of Sciences of the United States of America 97(17):9390-9395.
15. Ishimura, R., S. Ohsako, T. Kawakami, M. Sakaue, T. Aoki, and C. Tohyama. 2002. Altered protein profile and possible hypoxia in the placenta of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin exposed rats. Toxicology and Applied Pharmacology 185(3):197-206.
16. Xu, X.Q., C.K. Leow, X. Lu, X. Zhang, and J.S. Liu. 2004. Molecular classification of liver cirrhosis in a rat model by proteomics and bioinformatics. Proteomics 4(10):3235-3245.
17. Wolters, D.A., M.P. Washburn, and Y.R. Yates, III. 2001. An automated multi-dimensional protein identification technology for shotgun proteomics. Analytical Chemistry 73(23):5683-5690.
18. Washburn, M.P., R. Ulaszek, R. Deciu, D.M. Schieltz, and J.R. Yates, III. 2002. Analysis of quantitative proteomic data generated via multidimensional protein identification technology. Analytical Chemistry 74(7):1650-1657.
19. MacCoss, M.J., W.H. McDonald, A. Saraf, R. Sadygov, J.M. Clark, J.J. Tasto et al. 2002. Shotgun identification of protein modifications from protein complexes and lens tissue. Proceedings of the National Academy of Sciences of the United States of America 99(12):7900-7905.
20. Robertson, D.G., M.D. Reily, R.E. Sigler, D.F. Wells, D.A. Paterson, and T.K. Braden. 2000. Metabonomics: Evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. Toxicology Science 57:326-337.
21. Nicholls, A.W., E. Holmes, J.C. Lindon, J.P. Shockcor, R.D. Farrant, and J.N. Haselden. 2001. Metabonomic investigations into hydrazine toxicity in the rat. Chemical Research in Toxicology 14:975-987.
22. Waters, M.D., K. Olden, and R.W. Tennant. 2003. Toxicogenomic approach for assessing toxicant-related disease. Mutation Research 544:415-424.
23. Holmes, E., J.K. Nicholson, and G. Tranter. 2001. Metabonomic characterization of genetic variations in toxicological and metabolic responses using probabilistic neural networks. Chemical Research in Toxicology 14:182-191.
24. Stoyanova, R., J.K. Nicholson, J.C. Lindon, and T.R. Brown. 2004. Sample classification based on Bayesian spectral decomposition of metabonomic NMR data sets. Analytical Chemistry 76(13):3666-3674.
25. Griffin, J.L., S.A. Bonney, A. Mann, A.M. Hebbachi, and G.F Gibbons. 2001. An integrated reverse functional genomics and metabolic approach to understanding orotic acid-induced fatty liver. Physiology Genomics 17(2):140-149.
26. Robosky, L.C., D.F. Wells, D.A. Egnash, M.L. Manning, M.D. Reily, and D.G. Robertson. 2005. Metabonomic identification of two distinct phenotypes in Sprague-Dawley (Crl:CD[SD]) rats. Toxicology Science 87(1):277-284.
27. Lindon, J.C. 2003. Contemporary issues in toxicology: The role of metabonomics in toxicology and its evaluation by the COMET project. Toxicology and Applied Pharmacology 187:137-146.
28. Wilson, I.D., R. Plumb, J. Granger, H. Major, R. Williams, and E.M. Lenz. 2005. HPLC-MS-based methods for the study of metabonomics. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 817(1):67-76.
29. Gerber, S.A., J. Rush, O. Stemman, M.W. Kirschner, and S.P. Gygi. 2003. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proceedings of the National Academy of Sciences of the United States of America 100(12):6940-6945.
30. Lum, P.Y., Y.D. He, J.G. Slatter, J.F. Waring, and N. Zelinsky 2007. Gene expression profiling of rat liver reveals a mechanistic basis for ritonavir-induced hyperlipidemia. Genomics 90:464-473.
31. Stierum, R., W. Heijne, A. Kienhuis, B. van Ommen, and J. Groten. 2005. Toxicogenomics concepts and applications to study hepatic effects of food additives and chemicals. Toxicology and Applied Pharmacology 207(2 Suppl):179-188.
32. Pitot, III H.C., and Y.P. Dragan. 2001. Chemical carcinogenesis. In Casarett and Doull’s Toxicology, edited by Klaassen, C.D., vol. 6:266-280. New York: McGraw-Hill Companies Inc.
33. Li, Z., J. Dullmann, B. Schiedlmeier, M. Schmidt, C. von Kalle, J. Meyer et al. 2002. Murine leukaemia induced by retroviral gene marking. Science 296:497.
34. Ueda, K., and D. Ganem. 1996. Apoptosis is induced by N-myc expression in hepatocytes, a frequent event in hepadnavirus oncogenesis and is blocked by insulin-like growth factor II. Journal of Virology 70:1375-1383.
35. Ellisen, L.W., R.E. Palmer, R.G. Maki, V.B. Truong, and A. Tamayo. 2000. Cascades of transcriptional induction during human lymphocyte activation. European Journal of Cell Biology 80:321-328.
36. Hamalainen, H., H. Zhou, W. Chou, H. Hashizume, R. Heller, and R. Lahesmaa. 2001. Distinct gene expression profiles of human type 1 and type 2 T helper cells. Genome Biology 2(7):1-11.
37. Schaffer, A.L., A. Rosenwald, E.M. Hurt, J.M. Giltnane, L.T. Lam, and L.M. Staudt. 2001. Signatures of the immune response. Immunity 15:375-385.
38. Schmidt-Weber, C.B., J.G. Wohlfahrt, and K. Blaser. 2001. DNA arrays in allergy and immunology. International Archives of Allergy and Immunology 126:1-10.
39. Novak, R.F., and K.J. Woodcroft. 2000. The alcohol-inducible form of cytochrome P450 (CYP 2E1): Role in toxicology and regulation of expression. Archives of Pharmaceutical Research 23:267-282.
40. Stevens, J.L., H. Liu, M. Halleck, R.C. Bowes, Q.M. Chen, and B. van de Water. 2000. Linking gene expression to mechanisms of toxicity. Toxicology Letters 112-113.
41. Andersson, A.M., K.M. Grigor, E.R.D. Meyts, H. Leffers, and N.E. Skakkebaek, eds. 2001. Hormones and Endocrine Disrupters in Food and Water: Possible Impact on Human Health. Copenhagen: Munksgaard.
42. Safe, S.H. 2001. Endocrine disruptors and human health-is there a problem? An update. Environmental Health Perspectives 108:487-493.
43. Newbold, R.R. 2001. Effects of developmental exposure to diethylstilbestrol (DES) in rodents: Clues for other environmental estrogens. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica 109:S261-S271.
44. Newbold, R.R., B.C. Bullock, and J.A. McLachlan. 1984. Müllerian remnants of male mice exposed prenatally to diethylstilbestrol. Teratogenesis, Carcinogenesis, and Mutagenesis 7:337-389.
45. Williams, K., C. McKinnell, P.T.K. Saunders, M. Walker, J.S. Fisher, K.J. Turner et al. 2001. Neonatal exposure to potent and environmental oestrogens and abnormalities of the male reproductive system in the rat: Evidence for importance of the androgen-oestrogen balance and assessment of the relevance to man. Human Reproduction Update 7:236-247.